Author

I. A. Monteiro Barbosa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Czibere· 1 shared A. Di Ruscio· 1 shared A. K. Ebralidze· 1 shared A. Pichler· 1 shared A. Spittler· 1 shared A.-S. Schmolke· 1 shared B. Q. Trinh· 1 shared C. Kornauth· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Czibere

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 15, 2022

Genetic and epigenetic driven variation in regulatory regions activitycontribute to adaptation and evolution under endocrine treatment

N. Slaven, R. Lopes, E. Canale…·L. Magnani

This study identifies non-coding DNA alterations in hormone-dependent breast cancer that contribute to endocrine therapy resistance and disease progression.

DOI 10.1101/2022.02.15.480537

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBloodPeer-reviewedOct 14, 2021

Core binding factor leukemia hijacks T-cell prone PU.1 antisense promoter

E. van der Kouwe, G. Heller, A. Czibere…·P. B. Staber

The paper shows that CBF fusions in AML activate the PU.1 antisense promoter, reducing sense PU.1 transcription and blocking myeloid differentiation, similar to T-cell differentiation.

DOI 10.1182/blood.2020008971

humanbulk RNA-seq

𝕏 PostBluesky